Xcout Intel
Earli Inc.
Earli, Inc. is a U.S. biotechnology company developing synthetic-biology-based technologies for detecting and treating cancer. Its platform is designed to activate signals or therapeutic effects specifically within tumors, serving cancer patients and clinical researchers.
Subscribe to see Earli Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Earli Inc. at a glance
Earli Inc. is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $40M in January 2021. Xcout tracks 3 named people at Earli Inc., including David Suhy (Chief Scientific Officer). Xcout recorded 2 job postings from Earli Inc. in the last 90 days.
Earli Inc. leadership
- David SuhyChief Scientific Officer
- Cyriac RoedingCo-founder
- Sam GambhirFounder
Earli Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Earli Inc.
Xcout recorded 2 job postings from Earli Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Earli Inc.'s hiring signals →
Investors
Earli Inc. competitors
A few of Earli Inc.'s closest competitors — see the full list of competitors and alternatives →
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
T3 Pharmaceuticals AG is a biotechnology company that develops a proprietary technology platform utilizing bacteria to deliver targeted therapies. The company focuses on advancing a pipeline of Immuno-Oncology products designed to treat cancer patients.
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Serotiny is a synthetic biology company engineering multi-domain protein systems for cell therapies, including Chimeric Antigen Receptors (CARs). The firm operates within the biotechnology sector and has established biopharma technology agreements with partners like Twist Bioscience.
76Bio, Inc. is a biotechnology company founded in 2020 and based in Boston, United States. The company develops therapeutics for patients with life-threatening diseases by pioneering targeted protein degraders.
Get Earli Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Earli Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access